We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

120 hedge funds and large institutions have $242M invested in Surgalign Holdings, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

5% more funds holding

Funds holding: 114120 (+6)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

7% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 42

14% less capital invested

Capital invested by funds: $282M → $242M (-$39.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
3.35%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
11
Increased
39
Reduced
42
Closed
5
Calls
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$238K +$110K +573 +69%
Arrowstreet Capital
77
Arrowstreet Capital
Massachusetts
$230K +$65.2K +340 +34%
SRC
78
Shufro Rose & Co
New York
$227K -$12.8K -67 -5%
CAM
79
ClariVest Asset Management
California
$227K
Deutsche Bank
80
Deutsche Bank
Germany
$217K -$106K -552 -30%
PAM
81
Panagora Asset Management
Massachusetts
$209K +$100K +523 +74%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$204K
DIA
83
Denver Investment Advisors
Colorado
$202K -$7.67K -40 -3%
AIG
84
American International Group
New York
$191K +$383 +2 +0.2%
PCM
85
Prelude Capital Management
New York
$182K +$35.1K +183 +21%
BJ
86
BlackRock Japan
Japan
$148K +$71.5K +373 +75%
Prudential Financial
87
Prudential Financial
New Jersey
$129K
OAM
88
Oxford Asset Management
United Kingdom
$122K +$137K +714 New
RCM
89
Rotella Capital Management
Washington
$116K +$131K +681 New
ZIM
90
Zacks Investment Management
Illinois
$115K +$129K +675 New
PPCM
91
Pillar Pacific Capital Management
California
$113K +$51.2K +267 +67%
HW
92
Hancock Whitney
Mississippi
$87K +$97.9K +511 New
Susquehanna International Group
93
Susquehanna International Group
Pennsylvania
$85K -$45.6K -238 -32%
Nomura Holdings
94
Nomura Holdings
Japan
$79K -$328K -1,714 -79%
VKH
95
Virtu KCG Holdings
New York
$78K -$170K -888 -66%
MC
96
Menta Capital
California
$75K -$414K -2,159 -83%
TDC
97
Thompson Davis & Co
Virginia
$72K -$90.1K -470 -53%
SPC
98
Sigma Planning Corp
Michigan
$70K +$78.6K +410 New
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$68.9K +$47K +245 +154%
Principal Financial Group
100
Principal Financial Group
Iowa
$68K -$23.6K -123 -24%

SRGA Hedge Fund Activity: Q3 2015 in Review

120 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2015, worth a combined $242M — down 14% from $282M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SRGA positions and 5 closed out — a net gain of 6 holders — while 39 added to existing stakes and 42 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $3.07M. The largest seller was UBS AM, exiting entirely with an estimated $7.5M sold.

  • 120 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2015, up from 114 in Q2 2015.
  • Funds reported $242M of Surgalign Holdings, Inc. Common Stock stock for Q3 2015, down 14% quarter-over-quarter.
  • 11 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2015 and 5 closed out, a net change of +6 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2015 was BlackRock Advisors, an estimated $3.07M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2015 was UBS AM, an estimated $7.5M sold.

Based on aggregated 13F filings for Q3 2015.